© 2001 by European Society of Cardiology
ABLATION
Thrombogenicity of radiofrequency ablation procedures: what factors influence thrombin generation?
1St Michael's Hospital, Division of Cardiology University of Toronto ; 2Toronto General Hospital, Division of Cardiology University of Toronto Toronto, Canada; 3Toronto General Hospital, Divisions of Hematology and Internal Medicine University of Toronto Toronto, Canada
Abstract
AIMS: Thromboembolic complications have been reported after radiofrequency ablation but the low incidence of overt clinical events has been a limitation to the study of factors affecting thrombogenic risk. The aim of this study was to determine whether radiofrequency ablation has a procoagulant effect and to examine variables that affect thrombin generation.
METHODS AND RESULTS: Thirty-seven consecutive patients who underwent radiofrequency ablation were studied prospectively. Blood samples were assayed for thrombin-antithrombin III (TAT) and d-dimer (DD) at five different time points: (1) baseline; (2) after sheath insertion; (3) after electrophysiological study but before radiofrequency ablation; (4) at completion of the procedure; and (5) 24 h post-procedure.
TAT levels were within the normal range at baseline and increased significantly after sheath insertion from 2·1±1·2 µg l–1to 13·3±16·0 µg l–1(P< 0·01). Levels increased further to 24·0±19·9 µg l–1(P< 0·01) after electrophysiological study but did not increase after radiofrequency ablation. TAT normalized at 24 h. DD increased significantly from baseline values (230·2±176·8 ng ml–1) to 285·4±237·4 ng ml–1(P=0·019) after sheath insertion. There was a further significant increase after electrophysiological study to 423·4±324·3 ng ml–1(P< 0·01), and a slight but non-significant increase to 464·4±307·4 ng ml–1after radiofrequency ablation (P=0·159). DD remained elevated at 24 h. Procedure duration was the only variable that correlated with the relative increase in TAT and DD. The patients with the longest procedure durations had more catheters inserted, more radiofrequency applications and largely consisted of accessory bypass tract-mediated tachycardias. Heparin administration significantly blunted the relative increase in TAT after radiofrequency ablation (P=0·005).
CONCLUSION: Radiofrequency ablation procedures confer an increased risk of thrombosis. Catheterization and diagnostic study contribute largely to the thrombogenic stimulus. Thrombogenicity is increased in prolonged, complex procedures and is decreased in patients who have been administered heparin during the procedure.
Key Words: Radiofrequency ablation, thrombosis, heparin
Correspondence: Dr David Newman, 30 Bond St., Room 7-051Q, Toronto, Ontario, Canada, M5B 1W8. E-mail: newmand{at}smh.toronto.on.ca
References
[1] Ganz LI and Friedman PL. Supraventricular tachycardia. N Engl J Med 1995; 332: 162–173.
[2] Scheinman MM. Patterns of catheter ablation practice in the United States: results of the 1992 NASPE survey. Pacing Clin Electrophysiol 1994; 17: 873–875.[CrossRef][Medline]
[3] Hindricks G. The multicentre European radiofrequency survey (MERFS): complications of radiofrequency catheter ablation of arrhythmias. Eur Heart J 1993; 14: 1644–1653.
[4] Zhou L, Keane D, Reed G, Ruskin J. Thromboembolic complications of cardiac radiofrequency catheter ablation: a review of the reported incidence, pathogenesis and current research directions. J Cardiovasc Electrophysiol 1999; 10: 611–620.[Web of Science][Medline]
[5] Epstein MR, Knapp LD, Martindill M, et al. Embolic complications associated with radiofrequency catheter ablation. Atakr Investigator Group. Am J Cardiol 1996; 77: 655–658.[CrossRef][Web of Science][Medline]
[6] Kugler JD, Danford DA, Deal BJ, et al. Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Electrophysiology Society. N Engl J Med 1994; 330: 1481–1487.
[7] Greene TO, Huang SK, Wagshal AB. Cardiovascular complications after radiofrequency catheter ablation of supraventricular tachyarrhythmias. Am J Cardiol 1994; 74: 615–617.[CrossRef][Web of Science][Medline]
[8] Jais P, Shah DC, Haissaguerre M, et al. Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation. Am J Cardiol 1999; 84: 139R–146R.[CrossRef][Web of Science][Medline]
[9] Kunze KP, Hayen B, Geiger M. Ambulatory catheter ablation. Indications, results and risks. Herz 1998; 23: 135–140.[Web of Science][Medline]
[10] Mansourati J, Deharo JC, Graux P, et al. Short and medium-term outcome after radiofrequency ablation of the atrioventricular junction. Arch Mal Coeur Vaiss 1997; 90: 945–951.[Web of Science][Medline]
[11] Arch Mal Coeur Vaiss 1996; 89: 1599–1605 Le Groupe de Rythmologie de la Societe Francaise de Cardiologie. complications of radiofrequency ablation: A French experience.[Web of Science][Medline]
[12] Darpö B, Walfridsson H, Aunes M, et al. Incidence of sudden death after radiofrequency ablation of the atrioventricular junction for atrial fibrillation. Am J Cardiol 1997; 80: 1174–1177.[CrossRef][Web of Science][Medline]
[13] Haines DE and Verow AF. Observations on electrode-tissue interface temperature and effect on electrical impedance during radiofrequency ablation of ventricular myocardium. Circulation 1990; 82: 1034–1038.
[14] Huang SK, Graham AR, Hoyt RH, Odell RC. Transcatheter desiccation of the canine left ventricle using radiofrequency energy: a pilot study. Am Heart J 1987; 114: 42–48.[CrossRef][Web of Science][Medline]
[15] Katritsis DG, Hossein-Nia M, Anastasakis A. Myocardial injury induced by radiofrequency and low energy ablation: a quantitative study of CK isoforms, CK-MB, and troponin-T concentrations. Pacing Clin Electrophysiol 1998; 21: 1410–1416.[CrossRef][Medline]
[16] Katritsis D, Hossein-Nia M, Anastasakis A, et al. Use of troponin-T concentration and kinase isoforms for quantitation of myocardial injury induced by radiofrequency catheter ablation. Eur Heart J 1997; 18: 1007–1013.
[17] Chang DC and Reese TS. Changes in membrane structure induced by electroporation as revealed by rapid-freezing electron microscopy. Biophys J 1990; 58: 1–12.[Web of Science][Medline]
[18] Van Oeveren W, Crijns HJ, Korteling BJ, et al. Blood damage, platelet and clotting activation during application of radiofrequency or cryoablation catheters: a comparative in vitro study. J Med Eng Technol 1999; 23: 20–25.[CrossRef][Web of Science][Medline]
[19] Shuman MA and Levine SP. Thrombin generation and secretion of platelet factor 4 during blood clotting. J Clin Invest 1978; 61: 1102–1106.[Web of Science][Medline]
[20] Shifman MA and Pizzo SV. The in vivo metabolism of antithrombin III and antithrombin III complexes. J Biol Chem 1982; 257: 3243–3248.
[21] Franks JJ, Kirsch RE, Kao B, Kloppel TM. Fibrinogen and fibrinogen related peptides in cancer. In Marlani G (Ed.). Pathophysiology of Plasma Protein Metabolism 1984; London Macmillan.
[22] Mesters RM, Mikoteit T, Schiller M, Krings W, Ostermann H, Kienast S. Markers of coagulation activation for evaluation of the antithrombotic efficacy of heparin: a prospective study in acute deep venous thrombosis. Blood Coagul Fibrinolysis 1995; 6: 665–671.[Web of Science][Medline]
[23] Manolis AS, Melita-Manolis H, Vassilikos V, et al. Thrombogenicity of radiofrequency lesions: results with serial d-dimer determinations. J Am Coll Cardiol 1996; 28: 1257–1261.[Abstract]
[24] Hyers TM, Martin BJ, Pratt DS, Dreisin RB, Franks JJ. Enhanced thrombin and plasmin activity with exercise in man. J Appl Physiol 1980; 48: 821–825.
[25] Dorbala S, Cohen AJ, Hutchinson LA, Menchavez-Tan E, Steinberg JS. Does radiofrequency ablation induce a prethrombotic state? Analysis of coagulation system activation and comparison to electrophysiologic study. J Cardiovasc Electrophysiol 1998; 9: 1152–1160.[Web of Science][Medline]
[26] Anfinsen OG, Gjesdal K, Brosstad F, et al. The activation of platelet function, coagulation, and fibrinolysis during radiofrequency catheter ablation in heparinized patients. J Cardiovasc Electrophysiol 1999; 10: 503–512.[Web of Science][Medline]
[27] Calkins H, Sousa J, El-Atassi R, et al. Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test. N Engl J Med 1991; 324: 1612–1618.[Abstract]
[28] Warin J, Haissaguerre M, D'Ivernois C, le Metayer P, Montserrat P. Catheter ablation of accessory pathways: technique and results in 248 patients. Pacing Clin Electrophysiol 1990; 13: 1609–1614.[Medline]
[29] Thakur R, Klein G, Yee R, Zardini M. Embolic complications after radiofrequency catheter ablation. Am J Cardiol 1994; 74: 278–279.[CrossRef][Web of Science][Medline]
[30] Jackman WM, Beckman KJ, McClelland JH, et al. Treatment of supraventricular tachycardia due to atrioventricular nodal reentry by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med 1992; 327: 313–318.[Abstract]
[31] Circulation 1995; 92: 673–691 American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures.
[32] Michelucci A, Antonucci E, Conti AA. Electrophysiologic procedures and activation of the hemostatic system. Am Heart J 1999; 138: 128–132.[CrossRef][Web of Science][Medline]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. W. Schrickel, L. Lickfett, T. Lewalter, E. Mittman-Braun, S. Selbach, K. Strach, C. P. Nahle, J. O. Schwab, M. Linhart, R. Andrie, et al. Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation Europace, November 20, 2009; (2009) eup350v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. B. Rahmanian, J. G. Castillo, D. Mehta, D. H. Adams, and F. Filsoufi Epicardial Pulmonary Vein Isolation: A Long-Term Histologic and Imaging Animal Study Comparing Cryothermy Versus Radiofrequency Ann. Thorac. Surg., September 1, 2008; 86(3): 849 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Blanc, J. Almendral, M. Brignole, M. Fatemi, K. Gjesdal, E. Gonzalez-Torrecilla, P. Kulakowski, G. Y.H. Lip, D. Shah, C. Wolpert, et al. Consensus document on antithrombotic therapy in the setting of electrophysiological procedures Europace, May 1, 2008; 10(5): 513 - 527. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||